Managed Access AgreementMAA, NICE Managed Access
A formal arrangement between manufacturer and payer establishing conditions, such as price or eligibility criteria, under which a new treatment is made available.
Terms for how health technology assessment bodies appraise new technologies and reach funding decisions.
A formal arrangement between manufacturer and payer establishing conditions, such as price or eligibility criteria, under which a new treatment is made available.
The complete package of clinical and economic evidence a manufacturer provides in support of a coverage or reimbursement application.
Multi-criteria decision analysis is a family of structured methods that compares alternatives across multiple explicit criteria and incorporates judgments about the trade-offs among them.
An assessment process evaluating several related technologies for the same condition together within a single, coordinated review.